Back

Cardiomyopathy associated with pembrolizumab-induced hypophysitis

30 August 2025 (12:12 - 12:24)
Organised by: Logo
Congress Presentation Part of: Challenges in cardio-oncology (1) Cardio-Oncology ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Panagiotis Stachteas

Hippokration General Hospital of Thessaloniki, Thessaloniki (Greece)

3 More presentations in this session

Presentation thumbnail
Radiation-induced cardiac involvement
Doctor M. Herman Cavarra (Buenos Aires, AR)
Slides Video
Presentation thumbnail
Systemic anti-cancer therapy (SACT) as a contributing factor towards heart failure in an 80-year-old patient with lung squamous cell carcinoma
Doctor J. Brown (Newcastle-Upon-Tyne, GB)
Slides Video
Presentation thumbnail
Cardiac complications on a left lung cancer patient
Doctor A. Marc (Baia Mare, RO)
Slides Video

Access the full session

Session thumbnail
Challenges in cardio-oncology (1)
Video

The Event

Event poster

ESC Congress 2025

30 August 2025 12:12 CET
You may be interested in
thumbnail
Congress Session
Immune checkpoint inhibitors and the heart
thumbnail
Congress Presentation
Fatal pembrolizumab cardiotoxicity refractory to corticosteroid therapy: A case of atrial fibrillation, atrioventricular blocks, ventricular arrhythmias, and clinically suspected myocarditis
thumbnail
Congress Presentation
Acute myocarditis secondary to chemotherapy with subsequent complete heart block: diagnostic and therapeutic challenges

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources